Hematology CME
21 - 30 of 34 results
- FREE
Medscape Hematology-Oncology
CME activities of special interest to hematologists and oncologists. Medscape contains a variety of educational formats:
CONFERENCE COVERAGE – Reports of advances presented at major medical conferences; typically includes several tracks with news stories, expert interviews, and in-depth topic overviews.
CLINICAL UPDATE – Comprehensive original review article on scientific advances in a clinical topic.
FAST TRACK CLINICAL UPDATE – Narrowly focused original review article on scientific advances in a clinical topic.
CME-LIVE – Real-time online events with streaming video, synchronized visuals, and interactive questions and answers; archived for 1 year.
CLINICAL BRIEFS – Daily reports of major current medical research articles; 0.25 credits each
JOURNAL CME – Articles selected from a wide selection of peer-reviewed journals.
SPECIAL REPORT CME – Topic-based monthly email newsletter distributed to Medscape’s professional member database by specialty.INTERACTIVE PATIENT CASES – Original CME activity presented to the physician in an interactive, clinical case-based format. (See especially eMedicine CME Case Presentations.)
CME CIRCLE – Multimedia content certified by other accredited professional education providers, typically from live symposia or monographs, and then posted on Medscape and archived for one year.Target Audience: Hematologists and Oncologists
See full details chevron_right- Cost: Free
- Credit hours: Varies depending on course
- CME credits awarded by: Medscape and many other sponsoring organizations
- Format: On-Demand Online
- Material last updated: Continuously Updated
- FREE
Northwestern University: Feinberg School of Medicine: Office of Continuing Medical Education: Distance Learning
The Northwestern University Feinberg School of Medicine offers various up to date CME activities that offer CME credits.
Topics include:
Neuro-oncology, Cardiovascular Health, Echocardiographic Assessment, and many more.Target Audience: Various Specialties
See full details chevron_right- Cost: Varies depending on course
- Credit hours: Varies depending on course
- CME credits awarded by: Northwestern University Feinberg School of Medicine.
- Format: Live Course, On-Demand Online
Oncology for Practicing Physicians
The Oncology for Practicing Physicians course is:
• Comprehensive, modularized, interactive, asynchronous and online, with the flexibility to select all or some modules
• Designed, developed, and authored by expert McGill clinicians under the direction of a McGill scientific committee
• Accredited for family physicians Mainpro-M 1 and specialists MOC Section 2 credits
• Based on comprehensive needs assessments
• Supportive of self-directed learning
• Accessible from a variety of electronic devices, including smartphones and tablets
• Providing access to oncology experts through the Ask the Expert featureTarget Audiences:
See full details chevron_right
family physicians, specialists, trainees, medical students, nurses, and other healthcare professionals.- Cost: Varies depending on course
- Credit hours: 1.5 per course
- CME credits awarded by: Continuing Professional Development (CPD) McGill University.
- Format: On-Demand Online
- FREE
Society for Translational Oncology
Over 125 text-only courses in a comprehensive variety of hematology and oncology areas. Some recent topics are:
• Comparative Effectiveness Research in Oncology
• Oncology Comparative Effectiveness Research: A Multi-Stakeholder Perspective on Principles for Conduct and Reporting
• Progress in the biological understanding and management of breast cancer associated CNS metastases
• Multicenter Italian Experience in Liver Transplantation for Hepatocellular Carcinoma in HIV Infected Patients
• Prospective Head and Neck Cancer Research: a Four-Decade Bibliometric Perspective
• Role of Postoperative Vitamin D and/or Calcium Routine Supplementation in Preventing Hypocalcemia After ThyroidectomyTarget Audiences: Hematologists, Oncologists
See full details chevron_right- Cost: Free
- Credit hours: Varies depending on course (Most are 1 or less)
- CME credits awarded by: Society for Translational Oncology
- Format: On-Demand Online
- FREE
Paroxysmal nocturnal hemoglobinuria (PNH): Best practices and effective management
Activity Description / Statement of Need:
In this online, self-learning activity:
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired, hematopoietic stem cell disorder characterized by complement-mediated destruction and loss of erythrocytes and the eponymous clinical manifestation of pink-red discoloration of the urine due to presence of hemoglobin. PNH is a rare disorder with a reported incidence of clinically significant disease of between 1 to 2 cases per million. However, it is possible that this range may be underestimated, as a subset of patients remain undiagnosed. PNH occurs worldwide with no known specific ethnic or geographic distribution patterns.
Approximately 40% of patients with PNH saw at least five or more specialists before receiving a diagnosis. PNH diagnosis is complicated by the rarity of the disorder and the nonspecific findings, meriting continuing healthcare educational programming.
Target Audience:
The following healthcare professionals: Hematologists; physician assistants, nurse practitioners, and pharmacists specializing in hematology and transplant medicine; and any other healthcare professionals with an interest in or who may clinically encounter patients with PNH.
See full details chevron_right- Cost: Free
- Credit hours: 1
- CME credits awarded by: ScientiaCME
- Format: On-Demand Online
- Material last updated: 01/28/2022
- Expiration of CME credit: 01/28/2024
- FREE
OptumHealth Education Oncology
There are many Oncology courses on this site offering between .75 – 1 CME credits.
Topics covered include:
Cancer Pain Management, Hodgkins Lymphoma, Cancer Immunotherapy, and many more.Target Audience: Hematologists, Oncologists
See full details chevron_right- Cost: Free
- Credit hours: 0.75 - 1 per course
- CME credits awarded by: Various Sponsors
- Format: On-Demand Online
- FREE
Contemporary management strategies in the diagnosis and treatment of immune thrombocytopenia (ITP)
Activity Description / Statement of Need:
In this online, self-learning activity:
Immune thrombocytopenia (ITP) is a phenomenon characterized by a peripheral platelet count of less than 100 x 109/L in the absence of any discernable cause, with an increased risk of bleeding. Also known as thrombocytopenic purpura, it occurs in around two to four cases per 100,000 adults, with incidence peaking bimodally: Once between 20-30 years with female predominance and also at 60 years with even distribution between the sexes.
The diagnosis of ITP is one of exclusion and includes platelet autoantibody testing. However, it is complicated and associated with documented gaps in care, with preventable delays in diagnosis and misdiagnosis not uncommon. One study found that one in seven patients diagnosed with ITP were misdiagnosed and reclassified as they received additional clinical evaluation. Another study found that over 22% of patients with ITP did not receive guideline-recommended peripheral blood film examination. These diagnostic challenges have real-world consequences on patient lives, creating anxiety in 73% of patients who experience a delayed diagnosis.
Treatment goals include prevention of severe bleeding episodes, maintaining platelet counts for symptomatic patients, minimizing treatment toxicity, and maximizing health-related quality of life. Conventional therapy includes corticosteroids, intravenous immunoglobulin (IVIg), and anti-D IVIg. However, treatment challenges remain, including variability in practice between providers and high rates of relapse between following standard first-line therapies together with considerable patient frustration. Moreover, some patient subpopulations are more challenging to treat and are less likely to achieve therapeutic success.
Target Audience:
HCPs specializing in: hematology; physician assistants, nurse practitioners, nurses, pharmacists; and any other healthcare professionals with an interest in or who clinically encounter patients with ITP.
See full details chevron_right- Cost: Free
- Credit hours: 1.5
- CME credits awarded by: ScientiaCME
- Format: On-Demand Online
- Material last updated: April 09, 2022
- Expiration of CME credit: April 09, 2024
- FREE
Gaps in the identification and treatment of hemophilia B: what are the missing factors?
Activity Description / Statement of Need:
In this online, self-learning activity:
Hemophilia is a genetic disease caused by mutation of one of the genes for coagulation proteins leading to dangerous, uncontrolled bleeding. In hemophilia B, a mutation in the gene for factor IX (FIX) leads to an endogenous deficiency in the clotting factor. The incidence of hemophilia B is the same in all geographic regions, populations, and ethnic groups, affecting approximately 1 out of every 30,000 male births. The condition is diagnosed by measuring FIX activity, and patients with severe hemophilia have levels of 1% or less. Patients with severe hemophilia B are at risk for spontaneous, life-threatening bleeding episodes. Untreated, the life expectancy is approximately 20 years, and painful or even life-threatening morbidities include: intracranial hemorrhage, severe bleeding in other organ systems, musculoskeletal injury, and joint injury. In contrast, in people with moderate or mild hemophilia, abnormal bleeding usually occurs after minor trauma or surgery. Unfortunately, the literature shows that not only do clinicians struggle with the classification of hemophilia severity and that there are gaps in knowledge present that contribute to delayed diagnosis and treatment, with an attendant increase in morbidity and mortality. Challenges in diagnosis and classification are only the first of several gaps in care that patients with hemophilia face.
Target Audience:
The following HCPs: hematologists and pediatricians; physician assistants, nurse practitioners, and pharmacists who practice in hematology, and other HCPs who practice in hemophilia treatment center; and any other clinicians with an interest in or who clinically encounter patients with hemophilia B.
See full details chevron_right- Cost: Free
- Credit hours: 1
- CME credits awarded by: ScientiaCME
- Format: On-Demand Online
- Material last updated: April 23, 2022
- Expiration of CME credit: April 23, 2024
- FREE
Pyruvate kinase deficiency (PKD): zeroing in on gaps in identification and treatment
Activity Description / Statement of Need:
In this online, self-learning activity:
Pyruvate kinase (PK) is an enzyme that plays a major role in a metabolic pathway integral to the production of ATP, and a deficiency in the enzyme (PKD) is one of the most common enzyme-related glycolytic defects in a pathway integral to the production of ATP. It is transmitted as an autosomal recessive trait and is caused by mutations in the PKLR gene on chromosome 1, and over one hundred eighty of these mutations have been associated with PKD. While PKD affects approximately five people of European descent per 100,000 (data in other patient populations are lacking), it is one of the more frequent causes of chronic hemolysis. Anemia arising from the condition may range from mild and fully compensated to life-threatening in severity.
Target Audience:
Healthcare professionals specializing in: hematology; nurse practitioners, physician assistants, and pharmacists who specialize in hematology; and those who otherwise commonly care for or clinically encounter patients with PKD.
See full details chevron_right- Cost: Free
- Credit hours: .75
- Format: On-Demand Online
- Material last updated: May 12, 2022
- Expiration of CME credit: May 12, 2024
- FREE
Novel and practical approaches to the prevention of neutropenia associated with myelosuppressive chemotherapy
Activity Description / Statement of Need:
In this online, self-learning activity:
Neutropenia, a decrease in the number of a type of white blood cell (WBC) in the body, is a common complication in patients undergoing myelosuppressive chemotherapy that can result in serious, life-threatening infections. Febrile neutropenia (FN), or neutropenia accompanied by a fever, poses an even greater risk to patients and the frequent treatment complication results in over 100,000 hospitalizations in the U.S. each year. Neutropenia can manifest up to twelve days following treatment with a chemotherapy agent and FN occurs in about eight per 1,000 patients receiving chemotherapy. Fever is defined as a single oral temperature of 38.3+ °C or 38.0+ °C over the course of an hour, with neutropenia defined as less than 500 neutrophils/mcL or less than 1000 with a predicted decline to less 500 over the following 48 hours. Development of FN may lead to hospitalization with costs estimated at approximately $15,000 per visit, and it may also complicate care by reducing chemotherapy relative dose intensity (RDI) and possibly compromise treatment efficacy and lower survival rates.
Target Audience:
Oncologists and hematologists; physician assistants, nurse practitioners, and pharmacists who practice in oncology; and other HCPs with an interest in or who clinically encounter patients with FN or at risk of developing it.
See full details chevron_right- Cost: Free
- Credit hours: 1
- CME credits awarded by: ScientiaCME
- Format: On-Demand Online
- Material last updated: 06/02/2022
- Expiration of CME credit: 06/02/2024